Table 1. Characteristics of the Study Cohort at Baseline.

From: High Estimated Glomerular Filtration Rate and Risk of Cancer Mortality in a Japanese Cohort Study: The Ibaraki Prefectural Health Study

eGFR category (mL/min/1.73 m2) ≥90 60-89 45-59 <45
Men
Study size (Persons) 3,094 23,811 3,182 279
Age (Years) 57 ± 9 60 ± 10 66 ± 8 69 ± 7
Body mass index (kg/m2) 22.6 ± 2.9 23.3 ± 2.9 23.9 ± 3.0 23.7 ± 3.1
Systolic blood pressure (mmHg) 135 ± 18 136 ± 17 140 ± 17 144 ± 19
Diastolic blood pressure (mmHg) 80 ± 11 81 ± 11 82 ± 12 83 ± 12
Use of anti-hypertensive drugs (%) 13.3 18.1 34.2 52.3
Use of hypoglycemic drugs (%) 2.7 3.5 5.6 10.0
Total cholesterol (mg/dL) 189 ± 35 193 ± 35 197 ± 35 193 ± 39
High-density lipoprotein (mg/dL) 54.1 ± 15.5 54.1 ± 15.5 50.3 ± 15.5 46.4 ± 15.5
Use of lipid-lowering drugs (%) 0.7 1.1 2.2 3.2
Current Smoking (%) 43.6 36.5 24.5 20.1
Follow-up range (Years) 0.2-25.7 0.1-25.7 0.1-25.7 0.3-25.7
Follow-up (Person-years) 63,908 473,194 56,646 3,697
Women
Study size (Persons) 3,831 43,809 10,982 562
Age (Years) 54 ± 10 56 ± 10 66 ± 7 68 ± 8
Body mass index (kg/m2) 23.2 ± 3.2 23.5 ± 3.2 24.0 ± 3.3 24.2 ± 3.6
Systolic blood pressure (mmHg) 129 ± 18 131 ± 18 137 ± 17 141 ± 18
Diastolic blood pressure (mmHg) 76 ± 10 78 ± 11 79 ± 10 80 ± 11
Use of anti-hypertensive drugs (%) 10.8 15.7 35.4 51.8
Use of hypoglycemic drugs (%) 1.6 1.8 3.6 5.7
Total cholesterol (mg/dL) 201 ± 35 205 ± 35 213 ± 35 213 ± 43
High-density lipoprotein (mg/dL) 58.0 ± 15.5 58.0 ± 15.5 54.1 ± 15.5 50.3 ± 15.5
Use of lipid-lowering drugs (%) 2.1 2.8 5.2 4.3
Current smoker (%) 2.0 1.8 1.1 1.1
Follow-up range (Years) 0.1-25.7 0.1-25.7 0.1-25.7 0.4-25.7
Follow-up (Person-years) 86,119 973,528 220,235 8,649
Table 2. Numbers and Hazard Ratios of Cancer Mortalities among Different Grades of Renal Function.

From: High Estimated Glomerular Filtration Rate and Risk of Cancer Mortality in a Japanese Cohort Study: The Ibaraki Prefectural Health Study

eGFR, mL/min/1.73 m2 ≥90 60-89 45-59 <45
Population 6,925 67,620 14,164 732
Mean follow-up length, years 21.7 21.4 19.5 14.7
 Total mortalities 2,318 22,094 7,548 654
 Cancer mortalities 779 6,986 1,799 112
Cancer death rate, per 10,000 person-years 51.9 48.3 65.0 90.7
 Age- and sex-adjusted HR (95%CI) 1.14 (1.06-1.23) Reference 0.98 (0.93-1.03) 1.15 (0.95-1.39)
 Multivariable-adjusted HR (95%CI) 1.10 (1.02-1.18) Reference 0.98 (0.93-1.03) 1.14 (0.94-1.37)
PAGE TOP